Pablo de Renteria
Stock Analyst at Kepler Capital
(0.64)
# 4,264
Out of 5,119 analysts
347
Total ratings
43.3%
Success rate
-2.5%
Average return
Main Sectors:
Stocks Rated by Pablo de Renteria
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: BIM bioMérieux S.A. | Downgraded: Hold | €85.00 → €95.00 | €93.30 | +1.82% | 2 | Nov 5, 2026 | |
| BIT: DIA DiaSorin S.p.A. | Downgraded: Hold | €76.00 | €82.64 | -8.03% | 2 | Sep 2, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 670.00 | CHF 663.40 | +0.99% | 15 | May 8, 2026 | |
| BME: IDR Indra Sistemas, S.A. | Reiterated: Buy | €76.00 | €56.76 | +33.90% | 27 | May 6, 2026 | |
| BME: ROVI Laboratorios Farmaceuticos Rovi, S.A. | Reiterated: Buy | €90.00 → €83.00 | €68.60 | +20.99% | 36 | May 6, 2026 | |
| SWX: SFZN Siegfried Holding AG | Reiterated: Hold | CHF 85.00 | CHF 72.00 | +18.06% | 5 | Apr 24, 2026 | |
| BME: VIS Viscofan, S.A. | Reiterated: Buy | €74.00 | €55.60 | +33.09% | 56 | Apr 24, 2026 | |
| BME: EBRO Ebro Foods, S.A. | Reiterated: Hold | €18.10 | €18.08 | +0.11% | 40 | Feb 24, 2026 | |
| BME: ALM Almirall, S.A. | Reiterated: Buy | €13.30 → €14.20 | €11.22 | +26.56% | 49 | Feb 23, 2026 | |
| BME: FDR Fluidra, S.A. | Reiterated: Sell | €19.20 | €19.32 | n/a | 66 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €4.20 | €2.24 | n/a | 13 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €5.00 | €2.65 | n/a | 11 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $8.43 | n/a | 17 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €17.50 | €11.25 | n/a | 1 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €99.00 → €105.00 | €83.74 | n/a | 3 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 9,500p | 13,930p | n/a | 1 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €28.70 → €32.00 | €59.04 | n/a | 2 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €2.35 | €0.67 | n/a | 1 | Jul 29, 2019 |
bioMérieux S.A.
Nov 5, 2026
Downgraded: Hold
Price Target: €85.00 → €95.00
Current: €93.30
Upside: +1.82%
DiaSorin S.p.A.
Sep 2, 2026
Downgraded: Hold
Price Target: €76.00
Current: €82.64
Upside: -8.03%
Lonza Group AG
May 8, 2026
Reiterated: Buy
Price Target: CHF 670.00
Current: CHF 663.40
Upside: +0.99%
Indra Sistemas, S.A.
May 6, 2026
Reiterated: Buy
Price Target: €76.00
Current: €56.76
Upside: +33.90%
Laboratorios Farmaceuticos Rovi, S.A.
May 6, 2026
Reiterated: Buy
Price Target: €90.00 → €83.00
Current: €68.60
Upside: +20.99%
Siegfried Holding AG
Apr 24, 2026
Reiterated: Hold
Price Target: CHF 85.00
Current: CHF 72.00
Upside: +18.06%
Viscofan, S.A.
Apr 24, 2026
Reiterated: Buy
Price Target: €74.00
Current: €55.60
Upside: +33.09%
Ebro Foods, S.A.
Feb 24, 2026
Reiterated: Hold
Price Target: €18.10
Current: €18.08
Upside: +0.11%
Almirall, S.A.
Feb 23, 2026
Reiterated: Buy
Price Target: €13.30 → €14.20
Current: €11.22
Upside: +26.56%
Fluidra, S.A.
Jul 31, 2025
Reiterated: Sell
Price Target: €19.20
Current: €19.32
Upside: n/a
Jul 23, 2025
Reiterated: Buy
Price Target: €4.20
Current: €2.24
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: €5.00
Current: €2.65
Upside: n/a
Feb 29, 2024
Reiterated: Buy
Price Target: $19
Current: $8.43
Upside: n/a
Apr 21, 2023
Initiated Coverage: Buy
Price Target: €17.50
Current: €11.25
Upside: n/a
Dec 10, 2021
Reiterated: Buy
Price Target: €99.00 → €105.00
Current: €83.74
Upside: n/a
Dec 10, 2021
Reiterated: Buy
Price Target: 9,500p
Current: 13,930p
Upside: n/a
Mar 18, 2020
Downgraded: Hold
Price Target: €28.70 → €32.00
Current: €59.04
Upside: n/a
Jul 29, 2019
Reiterated: Buy
Price Target: €2.35
Current: €0.67
Upside: n/a